Huberman Lab
Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity
Andrew Huberman
The research and development process for a drug, the safety evaluation is incredibly expensive. So they want nothing more than to take a drug that's already been approved for one purpose and to take that already safety approved drug and find other uses. How are they not circling back to the off-label use and understanding of these compounds and
0
💬
0
Comments
Log in to comment.
There are no comments yet.